1
|
Tan RY, Ilham Z, Wan-Mohtar WAAQI, Abdul Halim-Lim S, Ahmad Usuldin SR, Ahmad R, Adlim M. Mushroom oils: A review of their production, composition, and potential applications. Heliyon 2024; 10:e31594. [PMID: 38845934 PMCID: PMC11153096 DOI: 10.1016/j.heliyon.2024.e31594] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2024] [Revised: 05/05/2024] [Accepted: 05/20/2024] [Indexed: 06/09/2024] Open
Abstract
This review delves into the world of mushroom oils, highlighting their production, composition, and versatile applications. Despite mushrooms' overall low lipid content, their fatty acid composition, rich in essential fatty acids like linoleic acid and oleic acid, proves nutritionally significant. Variations in fatty acid profiles across mushroom species and the prevalence of unsaturated fats contribute to their cardiovascular health benefits. The exploration extends to mushroom essential oils, revealing diverse volatile compounds through extraction methods like hydrodistillation and solvent-assisted flavor evaporation (SAFE). The identification of 1-octen-3-ol as a key contributor to the distinct "mushroom flavor" adds a nuanced perspective. The focus broadens to applications, encompassing culinary and industrial uses with techniques like cold pressing and supercritical fluid extraction (SFE). Mushroom oils, with their unique nutritional and flavor profiles, enhance gastronomic experiences. Non-food applications in cosmetics and biofuels underscore the oils' versatility. The nutritional composition, enriched with essential fatty acids, bioactive compositions, and trace elements, is explored for potential health benefits. Bioactive compounds such as phenolic compounds and terpenes contribute to antioxidant and anti-inflammatory properties, positioning mushroom oils as nutritional powerhouses. In short, this concise review synthesizes the intricate world of mushroom oils, emphasizing their nutritional significance, extraction methodologies, and potential health benefits. The comprehensive overview underscores mushroom oils as a promising area for further exploration and utilization. The characteristics of mushroom biomass oil for the use in various industries are influenced by the mushroom species, chemical composition, biochemical synthesis of mushroom, and downstream processes including extraction, purification and characterization. Therefore, further research and exploration need to be done to achieve a circular bioeconomy with the integration of SDGs, waste reduction, and economic stimulation, to fully utilize the benefits of mushroom, a valuable gift of nature.
Collapse
Affiliation(s)
- Rui Yeong Tan
- Biomass Energy Laboratory, Faculty of Science, Institute of Biological Sciences, Universiti Malaya, Kuala Lumpur, Malaysia
- Functional Omics and Bioprocess Development Laboratory, Faculty of Science, Institute of Biological Sciences, Universiti Malaya, Kuala Lumpur, Malaysia
| | - Zul Ilham
- Biomass Energy Laboratory, Faculty of Science, Institute of Biological Sciences, Universiti Malaya, Kuala Lumpur, Malaysia
| | - Wan Abd Al Qadr Imad Wan-Mohtar
- Functional Omics and Bioprocess Development Laboratory, Faculty of Science, Institute of Biological Sciences, Universiti Malaya, Kuala Lumpur, Malaysia
| | - Sarina Abdul Halim-Lim
- Faculty of Food Science and Technology, Universiti Putra Malaysia, 43400, Seri Kembangan, Selangor Darul Ehsan, Malaysia
| | - Siti Rokhiyah Ahmad Usuldin
- Agro-Biotechnology Institute, Malaysia (ABI), National Institutes of Biotechnology Malaysia (NIMB), HQ MARDI, 43400, Serdang, Selangor, Malaysia
| | - Rahayu Ahmad
- Halal Action Laboratory, Kolej GENIUS Insan, Universiti Sains Islam Malaysia, 71800, Nilai, Negeri Sembilan, Malaysia
| | - Muhammad Adlim
- Chemistry Department, FKIP, Universitas Syiah Kuala, Darussalam Banda Aceh, 23111, Indonesia
| |
Collapse
|
2
|
Lee SH, Song SY, Choi JH, Kim S, Lee HJ, Park JW, Park DH, Bae CS, Cho SS. Partial Purification and Biochemical Evaluation of Protease Fraction (MA-1) from Mycoleptodonoides aitchisonii and Its Fibrinolytic Effect. Antioxidants (Basel) 2023; 12:1558. [PMID: 37627553 PMCID: PMC10451839 DOI: 10.3390/antiox12081558] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2023] [Revised: 08/01/2023] [Accepted: 08/02/2023] [Indexed: 08/27/2023] Open
Abstract
The antioxidative proteolytic fraction, MA-1, was partially purified from Mycoleptodonoides aitchisonii. MA-1 was purified to homogeneity using a two-step procedure, which resulted in an 89-fold increase in specific activity and 42.5% recovery. SDS-PAGE revealed two proteins with a molecular weight of 48 kDa. The zymography results revealed proteolytic activity based on the MA-1 band. MA-1 was found to be stable in the presence of Na+, Ca2+, Fe3+, K+, and Mg2+. MA-1 was also stable in methanol, ethanol, and acetone, and its enzyme activity increased by 15% in SDS. MA-1 was inhibited by ethylenediaminetetra-acetic acid or ethylene glycol tetraacetic acid and exerted the highest specificity for the substrate, MeO-Suc-Arg-Pro-Tyr-pNA, for chymotrypsin. Accordingly, MA-1 belongs to the family of chymotrypsin-like metalloproteins. The optimum temperature was 40 °C and stability was stable in the range of 20 to 35 °C. The optimum pH and stability were pH 5.5 and pH 4-11. MA-1 exhibited stronger fibrinolytic activity than plasmin. MA-1 hydrolyzed the Aα, Bβ, and γ chains of fibrinogen within 2 h. MA-1 exhibited an antithrombotic effect in animal models. MA-1 was devoid of hemorrhagic activity at a dose of 80,000 U/kg. Overall, our results show that M. aitchisonii produces an acid-tolerant and antioxidative chymotrypsin-like fibrinolytic enzyme, and M. aitchisonii containing MA-1 could be a beneficial functional material for the prevention of cardiovascular diseases and possible complications.
Collapse
Affiliation(s)
- Sung-Ho Lee
- Department of Pharmacy, College of Pharmacy, Mokpo National University, Muan 58554, Republic of Korea; (S.-H.L.); (S.-Y.S.); (J.W.P.)
- Department of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Biomedical and Healthcare Research Institute, Mokpo National University, Mokpo 58554, Republic of Korea
| | - Seung-Yub Song
- Department of Pharmacy, College of Pharmacy, Mokpo National University, Muan 58554, Republic of Korea; (S.-H.L.); (S.-Y.S.); (J.W.P.)
- Department of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Biomedical and Healthcare Research Institute, Mokpo National University, Mokpo 58554, Republic of Korea
| | - Jun-Hui Choi
- Department of Food Science and Biotechnology, Gwangju University, Gwangju 61743, Republic of Korea; (J.-H.C.); (S.K.); (H.-J.L.)
| | - Seung Kim
- Department of Food Science and Biotechnology, Gwangju University, Gwangju 61743, Republic of Korea; (J.-H.C.); (S.K.); (H.-J.L.)
| | - Hyo-Jeong Lee
- Department of Food Science and Biotechnology, Gwangju University, Gwangju 61743, Republic of Korea; (J.-H.C.); (S.K.); (H.-J.L.)
| | - Jin Woo Park
- Department of Pharmacy, College of Pharmacy, Mokpo National University, Muan 58554, Republic of Korea; (S.-H.L.); (S.-Y.S.); (J.W.P.)
- Department of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Biomedical and Healthcare Research Institute, Mokpo National University, Mokpo 58554, Republic of Korea
| | - Dae-Hun Park
- College of Oriental Medicine, Dongshin University, Naju-si 58245, Republic of Korea;
| | - Chun-Sik Bae
- College of Veterinary Medicine, Chonnam National University, 77 Yongbong-ro, Buk-gu, Gwangju 61186, Republic of Korea;
| | - Seung-Sik Cho
- Department of Pharmacy, College of Pharmacy, Mokpo National University, Muan 58554, Republic of Korea; (S.-H.L.); (S.-Y.S.); (J.W.P.)
- Department of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Biomedical and Healthcare Research Institute, Mokpo National University, Mokpo 58554, Republic of Korea
| |
Collapse
|
3
|
Monokariotic fruiting body and clamp cell formation in Mycoleptodonoides aitchisonii (Bunaharitake). MYCOSCIENCE 2019. [DOI: 10.1016/j.myc.2019.01.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
4
|
Lee SY, Bae CS, Seo JH, Cho SS, Bae MS, Oh DS, Park DH. Mycoleptodonoides aitchisonii suppresses asthma via Th2 and Th1 cell regulation in an ovalbumin‑induced asthma mouse model. Mol Med Rep 2017; 17:11-20. [PMID: 29115454 PMCID: PMC5780072 DOI: 10.3892/mmr.2017.7901] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2016] [Accepted: 02/07/2017] [Indexed: 01/21/2023] Open
Abstract
Asthma is a chronic respiratory disease related to hyper‑responsiveness. The majority of patients suffer mild symptoms, however, some cases, especially in the young and the elderly, can lead to death by apnea. Mycoleptodonoides atichisonii (M. atichisonii) is an edible mushroom that has previously been reported to possess several bioactive properties, such as the synthesis of nerve growth factors, anti‑obesity effects and the ability to prevent cell death. In the current study, the authors evaluated the anti‑asthmatic effects of M. atichisonii using an ovalbumin‑induced asthma mouse model. M. atichisonii dose‑dependently suppressed the levels of white blood cells, eosinophils and immunoglobulin (Ig)E in BALB/c mice, resulting from ovalbumin‑induced asthma. M. atichisonii recovered the typical asthmatic morphological changes in lungs, such as mucous hyper‑secretion, epithelial layer hyperplasia, eosinophil infiltration and various cell surface molecules, such as CD3, CD4, CD8, CD19 and major histocompatibility complex class II. With the exception of CD19+ cells and IL‑12p40, M. atichisonii affected almost all factors related to asthma induction including the T helper (Th)1/Th2 transcription factors, T‑bet and GATA‑3, Th1‑related cytokines, Th2‑related cytokines and proinflammatory cytokines. In addition, M. atichisonii significantly inhibited the expression of IL‑5, IL‑13 and IL‑6. The authors concluded that M. atichisonii may be a promising drug candidate against asthma.
Collapse
Affiliation(s)
- Soon-Young Lee
- College of Oriental Medicine, Dongshin University, Naju, Jeollanam‑do 58245, Republic of Korea
| | - Chun-Sik Bae
- College of Veterinary Medicine, Chonnam National University, Gwangju 61186, Republic of Korea
| | - Ji-Hye Seo
- College of Oriental Medicine, Dongshin University, Naju, Jeollanam‑do 58245, Republic of Korea
| | - Seung Sik Cho
- Department of Pharmacy, College of Pharmacy, Mokpo National University, Muan, Jeollanam‑do 58554, Republic of Korea
| | - Min-Suk Bae
- Department of Environmental Engineering, College of Engineering, Mokpo National University, Muan, Jeollanam‑do 58554, Republic of Korea
| | - Deuk-Sil Oh
- Jeollanam‑do Wando Arboretum, Wando, Jeollanam‑do 59105, Republic of Korea
| | - Dae-Hun Park
- College of Oriental Medicine, Dongshin University, Naju, Jeollanam‑do 58245, Republic of Korea
| |
Collapse
|
5
|
Antioxidant and antidiabetic activities of mycelial and fruit-body extracts from Mycoleptodonoides aitchisonii. BIOTECHNOL BIOPROC E 2016. [DOI: 10.1007/s12257-016-0235-0] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
|
6
|
|